Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome

Gynecological Endocrinology

Volumn 27, Issue 11, 2011, Pages 931-934

  Wang, Qiushi ^a   Guo, Tao ^a   Tao, Yu ^a   Wang, Qiuyi ^a   Song, Yong ^a   Huang, Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

adipocytokines; insulin resistance; Polycystic ovarian syndrome

Indexed keywords

ADIPONECTIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LUTEINIZING HORMONE; PROGESTERONE; RESISTIN; TESTOSTERONE;

ADIPOCYTE; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADIPOKINES; ADIPONECTIN; ADULT; BLOOD GLUCOSE; CHINA; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN RESISTANCE; LEPTIN; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; RECEPTORS, LEPTIN; RESISTIN; TESTOSTERONE; YOUNG ADULT;

EID: 80053967541     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.569597     Document Type: Article

References (24)

1. Galluzzo A, Amato MC, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutri Metab Cardiovasc Dis 2008;18:511-518.
2. Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006;30: 45-53. (Pubitemid 46020329)
3. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005;152:389-394. (Pubitemid 40439491)
4. Shuldiner AR, Yang R, Gong DW. Resistin, obesity, and insulin resistance the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001;345:1345-1346.
5. Dunaif A. Polycystic ovary syndrome and obesity. In: Bjorntorp P, Brodoff BN, editors. Obesity, Philadelphia: J.B. Lippincott Co; 1992. pp 594-605.
6. Atamer A, Demir B, Bayhan G, Atamer Y, Ilhan N, Akkus Z. Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters. J Int Med Res 2008;36:96-105. (Pubitemid 351255975)
7. Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome. Fertil Steril 2004;82:1364-1368. (Pubitemid 39469462)
8. Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metabolism 2007;56:766-771. (Pubitemid 46734083)
9. Pehlivanov B, Mitkov M. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care 2009;14:153-159.
10. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271. (Pubitemid 26007816)
11. Hahn S, Haselhorst U, Quadbeck B, Tan S, Kimmig R,Mann K, Janssen OE. Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Eur J Endocrinol 2006;154:287-294.
12. Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril 2006;85:1441-1447.
13. Romualdi D, Campagna G, Selvaggi L Jr, Cento R, Proto C, Lanzone A, Guido M. Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome. Fertil Steril 2008;89:1273-1276. (Pubitemid 351681889)
14. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312. (Pubitemid 32151228)
15. Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 2004;81:361-366. (Pubitemid 38223917)
16. Xita N, Georgiou I, Tsatsoulis A, Kourtis A, Kukuvitis A, Panidis D. A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil Steril 2004;82:1466-1467. (Pubitemid 39469483)
17. Ouchi N, Kihara S, Arita Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived acrophages. Circulation 2001;103:1057-1063. (Pubitemid 32200177)
18. Stefan N, Stumvoll M. Adiponectin-its role in metabolism and beyond. Horm Metab Res, 2002;34:469-474.
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, PratleyRE, Tataranni PA. Hypoadiponectinaemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. JClinEndocrinolMetab2001;86:1930-1935. (Pubitemid 32472900)
20. Gulcelik NE, Aral Y, Serter R, Demir Y, Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2006;22:511-515. (Pubitemid 44657947)
21. Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and ameta-analysis.HumReprod Update 2009;15:297-307.
22. Orio F Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G, Vettor R. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2619-2623. (Pubitemid 36724434)
23. Yilmaz M, Bukan N, Demirci H, Ozturk C, Kan E, Ayvaz G, Arslan M. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:246-252.
24. Majuri A, Santaniemi M, Rautio K, Kunnari A, Vartiainen J, Ruokonen A, Kesaniemi YA, Tapanainen JS, Ukkola O, Morin-Papunen L. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebocontrolled study. Eur J Endocrinol 2007;156:263-269. (Pubitemid 46554522)